1.
Firstenberg MS, Dyke CM, Angiolillo DJ, Ramaiah C, Price M, Brtko M, Welsby I, Chandna H, Holmes DR, Voeltz M, Tummala P, Hutyra M, Manoukian SV, Prats J, Todd M, Liu T, Chronos N, Dietrich M, Montalescot G, Cannon LA, Topo EJ. Safety and Efficacy of Cangrelor, an Intravenous, Short-Acting Platelet Inhibitor in Patients Requiring Coronary Artery Bypass Surgery. HSF [Internet]. 2015Apr.3 [cited 2024Mar.28];16(2):E60-E69. Available from: https://journal.hsforum.com/index.php/HSF/article/view/443